Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors
Clinical trial NCT04118114 · COMPLETED
Trial details
- NCT number
- NCT04118114
- Sponsor
- National Cancer Centre, Singapore
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-03
- Primary completion
- 2025-10-17
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.